From 2017 to 2020, we worked on developing a technology that focuses on collaboration and exchange in the field of autism.
When the coronavirus reached Canada in early 2020, we decided to face this pandemic by widening the scope of our technology from autism to neurodiversity and making it available to all.
To meet the needs of our clients, we currently offer two products: Mylin et Synerpsy